Why Viking Therapeutics Stock Got Mashed on Monday

·2 min read
Why Viking Therapeutics Stock Got Mashed on Monday

The clinical trial has been halted by the FDA for now, pending the submittal of a preclinical study.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting